COMPUTER-IMPLEMENTED METHOD FOR THE SIMULATION OF MYOCARDIAL BLOOD FLOW UNDER STRESS CONDITIONS

    公开(公告)号:US20250054639A1

    公开(公告)日:2025-02-13

    申请号:US18720084

    申请日:2022-12-12

    Abstract: A computer-implemented method for the simulation of myocardial blood flow under stress conditions comprises a step of generating a simulated multi-physics model of a myocardial perfusion, wherein the step of generating further comprises: a step of generating a simulated model of the epicardial vessels based on a three-dimensional fluid-dynamics description; a step of generating a simulated model of the intramural vessels based on a multi-compartment porous medium; a step of coupling the simulated model of the epicardial vessels and the simulated model of the intramural vessels; a step of automatic calibration of physical parameters of the simulated multi-physics model of a myocardial perfusion under stress conditions, wherein the calibrated physical parameters are permeability tensors, conductances between the epicardial coronary arteries and the intramural vessels, and inter-compartment conductances between the compartments.

    GPR17-MODULATING COMPOUNDS, DIAGNOSTIC AND THERAPEUTIC USES THEREOF
    4.
    发明申请
    GPR17-MODULATING COMPOUNDS, DIAGNOSTIC AND THERAPEUTIC USES THEREOF 审中-公开
    GPR17调节化合物,其诊断和治疗用途

    公开(公告)号:US20150094348A1

    公开(公告)日:2015-04-02

    申请号:US14556007

    申请日:2014-11-28

    Abstract: Disclosed are compounds able to modulate the activity of the GPR17 receptor in a highly specific way, which are useful in the treatment and diagnosis of diseases or dysfunctions involving the activation of said receptor. In particular, the compounds according to the invention can be used for neuroprotective and/or reparatory purposes, in cerebral, cardiac and renal ischaemia, in cerebral trauma, in chronic neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), and in demyelinating diseases such as multiple sclerosis.

    Abstract translation: 公开了能够以高度特异性的方式调节GPR17受体的活性的化合物,其可用于治疗和诊断涉及所述受体活化的疾病或功能障碍。 特别地,根据本发明的化合物可用于脑,心脏和肾脏局部缺血,脑创伤,慢性神经变性疾病如肌萎缩性侧索硬化(ALS)中的神经保护和/或修复目的,以及脱髓鞘疾病 作为多发性硬化。

Patent Agency Ranking